期刊文献+

HMGB1及MMP-9在子宫内膜癌组织中表达的意义 被引量:7

Expression and clinical significance of HMGB1 and MMP-9 in endometrial carcinoma
原文传递
导出
摘要 目的探讨高迁移率蛋白B1(HMGB1)、基质金属蛋白酶-9(MMP-9)m RNA和蛋白在子宫内膜癌组织中表达水平及临床意义。方法应用实时荧光定量RT-PCR及Western印记法检测正常子宫内膜组织、单纯型增生症子宫内膜组织、非典型增生子宫内膜组织和子宫内膜癌Ⅰ期、Ⅱ期及Ⅲ期组织中HMGB1、MMP-9 m RNA和蛋白的表达水平。结果与正常子宫内膜组织比较,子宫内膜癌组织HMGB1、MMP-9 m RNA及蛋白的表达量明显升高,差异有统计学意义(P<0.05);子宫内膜癌组织HMGB1、MMP-9蛋白的表达上调与手术病理分期、淋巴结转移及浸润深度有关(P<0.05),与癌组织的分化程度无关(P>0.05);子宫内膜癌组织中,HMGB1蛋白与MMP-9蛋白的表达呈正相关(r=0.900,P<0.05)。结论 HMGB1、MMP-9在子宫内膜癌的发生、发展及转移的过程中起着重要的作用,其有望成为子宫内膜癌的早期诊断及预后评价的分子标志物。 Objective To investigate theexpression and clinical significance of high mobility group box1 protein (HMGB1) and matrix metalloproteinase-9 (MMP-9) in endometrial carcinoma. Method The expression levels of HMGB1 and MMP-9 were detected by Q-PCR and Western blot in the normal endometrial tissue, endometrial hyperplasia,atypical endometrial hyperplasia, and endometrial cancer (stageⅠ, Ⅱ, Ⅲ ). Results Q-PCR and Western blot results showed that in comparison with normal group ,the expression levels of HMGB1 and MMP-9 in endometrial carcinoma tissues were significantly increased (P〈0.05). The expression levels of HMGB1 and MMP-9 were correlated with FIGO stage, lymph node metastasis and invasion depth (P〈0.05).The expression level of HMGB1 was positively correlated with MMP-9 expression level (r=0.900,P〈0.05). Conclusions HMGB1, MMP-9 may play an important role in the development and metastasis of endometrial carcinoma. It may be able to use as a molecular marker for early diagnosis and prognosis evaluation of the endometrial carcinoma.
作者 段玉真 周晓慧 张玉娟 韩冰 DUAN Yu-zhen ZHOU Xiao-hui ZHANG Yu-juan HAN Bing(The Affiliated Hospital of Chengde Medical University, Chengde ,Hebei 067000, Chin)
出处 《热带医学杂志》 CAS 2016年第11期1371-1374,共4页 Journal of Tropical Medicine
基金 河北省科技厅基金(14277766D)
关键词 子宫内膜癌 HMGB1 MMP-9 RT—PCR WESTERN BLOT Endometrialcarcinoma HMGB1 MMP-9 RT-PCR Westem blot
  • 相关文献

参考文献3

二级参考文献32

  • 1Pandey V,Jung Y,Kang J,et al. Artemin reduces sensitivity to doxorubicin and paclitaxed in endometrial carcinoma cells through specific regulation of CD24[J]. Transl Oncol, 2010, 3(4):218-229.
  • 2Tang JZ, Kong XJ, Kang J, et al. Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL-2[J]. Mol Cancer Ther,2010,9(6) :1697-1708.
  • 3Kang J,Perry JK,Pandey V,et al. Artemin is oncogenic for human mammary carcinoma cells [J]. Oncogene, 2009,28 (19) 2304-2045.
  • 4Xu D, Mckee CM,Cao Y, et al. Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1 [J]. Cancer Res,2010,70(17):6988-6998.
  • 5Shin SM, Cho KS, Choi MS, et al. Urokinase-type plasminogen activator induces BV-2 microglial cell migration through activation of matrix metalloproteinase-9 [J]. Neuroehem Res, 2010, 35(7):976-985.
  • 6Yoshida N, Kobayashi K, Yu L, et al. Inhibition of TRPA1 channel activity in sensory neurons by the glial cell line-derived neu- rotrophic factor family member, artemin[J]. Mol Pain, 2011,7(1):41-50.
  • 7Banerjee A,Wu ZS,Qian P,et al. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative marnniary carcinoma [J]. Breast Cancer Res, 2011, 13 (6) : R112.
  • 8Kamat AA,Fletcher M,Gruman LM,et al. The clinical rel-evance of stromal matrix metalloproteinase expression in ovarian cancer[J]. Clin Cancer Res, 2006,12(6) : 1707-1714.
  • 9Jemal A, Siegel R, Xu J, et al. Cancer statistics,2010 [ J ]. CA Cancer J Clin,2010,60(5) :277-300.
  • 10Tang D, Kang R, Zeh HJ 3rd, et al. High-mobility group box 1 and cancer[J]. Biocbim Biophys Acta,2010,1799 (1-2) :131-140.

共引文献20

同被引文献47

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部